Cargando…
Endothelial TLR4 Expression Mediates Vaso-Occlusive Crisis in Sickle Cell Disease
Heme, released from red blood cells in sickle cell disease (SCD), interacts with toll-like receptor 4 (TLR4) to activate NF-κB leading to the production of cytokines and adhesion molecules which promote inflammation, pain, and vaso-occlusion. In SCD, TLR4 inhibition has been shown to modulate heme-i...
Autores principales: | Beckman, Joan D., Abdullah, Fuad, Chen, Chunsheng, Kirchner, Rachel, Rivera-Rodriguez, Dormarie, Kiser, Zachary M., Nguyen, Aithanh, Zhang, Ping, Nguyen, Julia, Hebbel, Robert P., Belcher, John D., Vercellotti, Gregory M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851052/ https://www.ncbi.nlm.nih.gov/pubmed/33542720 http://dx.doi.org/10.3389/fimmu.2020.613278 |
Ejemplares similares
-
Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia
por: Belcher, John D., et al.
Publicado: (2018) -
The Fucosylation Inhibitor, 2-Fluorofucose, Inhibits Vaso-Occlusion, Leukocyte-Endothelium Interactions and NF-ĸB Activation in Transgenic Sickle Mice
por: Belcher, John D., et al.
Publicado: (2015) -
Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction
por: Belcher, John D., et al.
Publicado: (2018) -
The BACH1 inhibitor ASP8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell disease
por: Belcher, John D., et al.
Publicado: (2023) -
Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical Evidence
por: Gentinetta, Thomas, et al.
Publicado: (2022)